Publication:
3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: Application of molecular field analysis

dc.contributor.authorNunthanavanit P.
dc.contributor.authorAnthony N.G.
dc.contributor.authorJohnston B.F.
dc.contributor.authorMackay S.P.
dc.contributor.authorUngwitayatorn J.
dc.date.accessioned2021-04-05T04:31:58Z
dc.date.available2021-04-05T04:31:58Z
dc.date.issued2008
dc.date.issuedBE2551
dc.description.abstractThree-dimensional quantitative structure-activity relationship (3D-QSAR) models were developed for chromone derivatives against HIV-1 protease using molecular field analysis (MFA) with genetic partial least square algorithms (G/PLS). Three different alignment methods: field fit, pharmacophore-based, and receptor-based were used to derive three MFA models. All models produced good predictive ability with high cross-validated r2 (r2 cv), conventional r2, and predictive r2 (r 2pred) values. The receptor-based MFA showed the best statistical results with r2cv = 0.789, r2 = 0.886, and r2pred = 0.995. The result obtained from the receptor-based model was compared with the docking simulation of the most active compound 21 in this chromone series to the binding pocket of HIV-1 protease (PDB entry 1AJX). It was shown that the MFA model related well with the binding structure of the complex and can provide guidelines to design more potent HIV-1 protease inhibitors. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA.
dc.format.mimetypeapplication/pdf
dc.identifier.citationArchiv der Pharmazie. Vol 341, No.6 (2008), p.357-364
dc.identifier.doi10.1002/ardp.200700229
dc.identifier.issn3656233
dc.identifier.other2-s2.0-50949092681
dc.identifier.urihttps://hdl.handle.net/20.500.14740/3970
dc.rights.holderScopus
dc.subject.otherChromone derivative
dc.subject.otherProteinase inhibitor
dc.subject.otherChromone derivative
dc.subject.otherP16 protease, Human immunodeficiency virus 1
dc.subject.otherProteinase
dc.subject.otherProteinase inhibitor
dc.subject.otherArticle
dc.subject.otherDrug protein binding
dc.subject.otherMolecular model
dc.subject.otherPharmacophore
dc.subject.otherPredictive validity
dc.subject.otherPriority journal
dc.subject.otherQuantitative structure activity relation
dc.subject.otherSimulation
dc.subject.otherThree dimensional imaging
dc.subject.otherAlgorithm
dc.subject.otherBinding site
dc.subject.otherChemical structure
dc.subject.otherChemistry
dc.subject.otherConformation
dc.subject.otherDrug design
dc.subject.otherRegression analysis
dc.subject.otherAlgorithms
dc.subject.otherBinding Sites
dc.subject.otherChromones
dc.subject.otherDrug Design
dc.subject.otherHIV Protease
dc.subject.otherHIV Protease Inhibitors
dc.subject.otherLeast-Squares Analysis
dc.subject.otherModels, Molecular
dc.subject.otherMolecular Conformation
dc.subject.otherQuantitative Structure-Activity Relationship
dc.title3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: Application of molecular field analysis
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-50949092681&doi=10.1002%2fardp.200700229&partnerID=40&md5=2a49c59d1f6f111004e25d0b3640205e

Files